Skip to the page

Data / Crowdfunding / Bay Remedies Inc

Bay Remedies Inc: crowdfunding raise on MainVest, Inc., $15,000 to $20,000 (2022)

Bay Remedies Inc, a company, filed a Form C with the SEC on May 20, 2022 to raise $15,000 to $20,000 in debt through MainVest, Inc.. The offering closed on August 19, 2022. In its most recent fiscal year it reported $0 in revenue and $0 in net income, with 2 employees.

SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.

Website
www.facebook.com/bayremedies
Funding portal
MainVest, Inc.
SEC CIK
0001911297

Offering terms

From the amendment filed May 20, 2022.

Security
Debt
Price
$1.00
Target
$15,000
Maximum
$20,000
Deadline
August 19, 2022
Portal compensation
MainVest will be paid 3% of the amount raised from persons introduced by the Issuer to the Offering, and 9% of the amount raised from all other investors in the Offering. MainVest does not receive compensation if the offering is not successful.

Financials

From the Form C/A filed May 20, 2022.

Most recent fiscal yearPrior fiscal yearSource
Revenue$0$0sec.gov
Cost of goods sold$0$0sec.gov
Net income$0$0sec.gov
Taxes paid$0$0sec.gov
Total assets$0$0sec.gov
Cash$0$0sec.gov
Accounts receivable$0$0sec.gov
Short-term debt$0$0sec.gov
Long-term debt$0$0sec.gov

Filings

FiledFilingTargetMaximumDeadlineNoteSource
August 22, 2022WithdrawalNot listedNot listedsec.gov
May 20, 2022Amendment$15,000$20,000August 19, 2022Issuer is extending the deadline to make an investment.sec.gov
February 15, 2022Offering$15,000$20,000May 20, 2022sec.gov

All filings on sec.gov

Updated August 22, 2022. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.